BNX Product Development Process

At BioNexus, product development is a structured yet flexible process that transforms early-stage concepts into fully launched products. Our five-phase framework integrates the principles of agile iteration with rigorous engineering discipline, drawing inspiration from the U.S. Department of Defense (DoD) Technology Readiness Levels (TRL 1–9) to assess and track product maturity.

---

Technology Readiness Levels (TRLs)

The DoD defines TRLs a standardized scale to assess the maturity of a technology. This 9-level framework helps align development stages with risk and readiness for deployment:

• TRL 1–2: Conceptual Foundations
  Basic principles are observed (TRL 1), and initial concepts and applications are formulated (TRL 2).
• TRL 3–5: Proof & Validation
  Critical technologies are demonstrated through analytical studies and lab-based PoCs (TRL 3–4), followed by validation of components in relevant environments (TRL 5).
• TRL 6–7: Prototyping in Context
  System-level prototypes are demonstrated in relevant (TRL 6) and then operational environments (TRL 7), integrating technologies into functional systems.
• TRL 8–9: Qualification & Deployment
  Final systems are tested, qualified (TRL 8), and successfully used in mission operations (TRL 9), indicating full readiness for commercialization or field use.

This framework guides BioNexus in mapping technical progress to clear, measurable readiness milestones.

---

BioNexus Product Development Phases

Phase 1: Concept & Technology Discovery (TRL 1–2 | 0.5–3 mo)

This investigation phase focuses on:

• Developing the core product concept and its initial high-level requirements.
• Outlining critical enabling technologies.
• Identifying and evaluating the highest-risk technical elements through basic calculations and simulations.
• Conducting early experiments to validate fundamental principles.
  It is highly iterative and focused on rapid de-risking of the unknown.

Phase 2: Technology Development & Feasibility Studies (TRL 3–4 | 3–12 mo)

Building on Phase 1 discoveries:

• Refine product requirements.
• Construct PoC devices targeting the most critical technologies, potentially exploring multiple paths.
• Stand up a nimble R&D production line.
• Develop rapid testing methodologies to evaluate concepts and inform manufacturing.
• Validate core components in a laboratory setting.
• Begin shaping scalable manufacturing strategies based on technical feasibility and cost goals.

Phase 3: Product & Process Development (TRL 5–7 | 6–24 mo)

The heart of commercialization:

• Deepen product specs to reflect user and market feedback.
• Build functional prototypes to test feasibility in both lab and operational environments.
• Mature designs through iterations of minimally viable prototypes.
• Transition R&D production into a more robust NPI-capable line.
• Conduct design freeze once the product meets all technical requirements under operational conditions.

Phase 4: Product & Process Validation (TRL 8 | 3–6 mo)

Following final design freeze:

• Fine-tune manufacturing processes, documentation, and quality controls for production scale.
• Validate the complete product with real users in its intended environment.

Phase 5: Product Launch & Post-Launch Support (TRL 9)

• Launch product to initial customers.
• Continue scaling production while refining yield, cost, and quality.
• Provide ongoing support and enhancements based on field performance.

---

A Non-Linear, Iterative Journey

While presented as linear, the BioNexus development pathway is inherently iterative. Projects often loop back to earlier phases as new knowledge surfaces. Activities from different phases frequently overlap—for example, core technology development may still occur during Phase 3. Quality systems, documentation, and manufacturing processes evolve continuously, scaled appropriately to the product’s maturity level.